-
- Morinaka Setsuko
- Kansaidenryoku Hospital
-
- Yoshinobu Toshiko
- Kansaidenryoku Hospital
-
- Kamamoto Yasutoshi
- Kansaidenryoku Hospital
Bibliographic Information
- Other Title
-
- トブラシンの鼻ネブライザー療法の検討 その安全性に関して
- トブラシン ノ ビ ネブ ライザー リョウホウ ノ ケントウ ソノ アンテイセ
- その安全性に関して
Search this article
Abstract
Tobramycin was administered nasally via a nebulizer and the tobramycin activity in the serum was examined.<br>In normal persons who received tobramycin nasally of 17.5mg, 35mg or 70mg, the activity of tobramycin in their serum was 0μg/ml or 0.3μg/ml. In patients with chronic sinusitis receiving tobramycin of 17.5mg several times (from 5 to 71 times), the serum concentrations were also 0 or 0.3μg/ml. No patients, receiving tobramycin complained of the symptoms due to its toxicity and nobody showed abnormalities in various examinations.<br>It is, therefore, conclude that it is safe to use tobramycin by means of a nasal nebulizer.
Journal
-
- Practica Oto-Rhino-Laryngologica
-
Practica Oto-Rhino-Laryngologica 75 (11), 2219-2223, 1982
The Society of Practical Otolaryngology
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390001204264846720
-
- NII Article ID
- 130001814165
-
- NII Book ID
- AN00107089
-
- ISSN
- 18844545
- 00326313
-
- NDL BIB ID
- 2617479
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- NDL
- Crossref
- CiNii Articles
-
- Abstract License Flag
- Disallowed